Learn More
Medchemexpress LLC Nvp-tae 226 | 761437-28-9 | MFCD12031516 | 99.8% | 468.94 g·mol⁻¹ | C23H25ClN6O3 | 5 MG

Supplier: Medchemexpress LLC HY132035MG
NVP-TAE 226 is an ATP-competitive small-molecule inhibitor of focal adhesion kinase (FAK) and insulin-like growth factor 1 receptor (IGF-1R), used in cellular and preclinical cancer research to probe signaling pathways and evaluate effects on proliferation, migration, and survival.
- Potent inhibition of FAK and Pyk2 with low-nanomolar IC50s.
- Also inhibits IGF-1R and insulin receptor, enabling study of connected signaling networks.
- Suitable for in vitro assays and preclinical efficacy models.
- Available as solid and solution formulations for flexible dosing.
- High purity appropriate for research applications.
- Stable under recommended storage conditions for prolonged shelf life.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.